Vitro America, Inc. – Trademark Portfolio
Entity Type: 03
Vitro America, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ENVISION THE POSSIBILITIES. The owner is based in Memphis, TN.
Suite 300
965 Ridge Lake Blvd.
Memphis, TN 38120
Showing of trademarks Trademarks
Trademark Classifications
Vitro America, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Advertising; business management; business administration; office functions
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does Vitro America, Inc. have?
Vitro America, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 6 cancelled.
What trademark classes does Vitro America, Inc. file in?
Vitro America, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 11 (Environmental Control), Class 20 (Furniture). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are Vitro America, Inc.'s most well-known trademarks?
Vitro America, Inc.'s registered trademark portfolio includes well-known marks such as ENVISION THE POSSIBILITIES. These are among 1 currently registered trademark in the portfolio.
What is Vitro America, Inc.'s trademark registration success rate?
Vitro America, Inc. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.